No Data
Earnings Preview: CRVS to Report Financial Results Post-market on November 12
Express News | Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2024 Financial Results on November 12, 2024
Corvus Pharmaceuticals Options Imply 12.0% Move in Share Price Post-earnings
Corvus Stock Climbs 7% Following Mizuho Upgrade
Mizuho Securities Upgrades Corvus Pharmaceuticals(CRVS.US) to Buy Rating, Announces Target Price $12
Express News | Corvus Pharmaceuticals Inc : Mizuho Raises Target Price to $12 From $3.5